A Covid antibody cocktail drug used to treat former US President Donald Trump has finally been approved for UK patients. Britain's medical regulator gave Ronapreve the green light after a major UK study found it could prevent prevent infection and treat patients who were already sick. It showed that among patients with at least one risk factor for severe Covid, it slashed their risk of death or hospitalisation by 70 per cent. ,,, ...The drug has also been shown to dramatically reduced the risk of catching Covid, but protection only lasts for a month. UK health officials will now decide...